Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
Subscribe To Our Newsletter & Stay Updated